Bellevue Group’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Bellevue Group's ANRO Position: Q3 2026 in Review
Bellevue Group opened a new position in Alto Neuroscience (ANRO) in Q3 2026: 1,163,588 shares worth $29.7M. The stake represents 0.62% of the portfolio and ranks #42 among its holdings.
133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Bellevue Group held 1,163,588 shares of Alto Neuroscience worth $29.7M as of Q3 2026.
- Alto Neuroscience was a new Bellevue Group position in Q3 2026.
- Alto Neuroscience made up 0.62% of Bellevue Group's portfolio in Q3 2026, its #42 holding.
- 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.